Otex Ear Drops For The Treatment Of Acute And Chronic Sensorineural Hearing Loss

Tinnitus which is often a consequence of sensorineural hearing loss, which, in turn, is caused by the problems with blood circulation in the vertebro-basilar basin can be treated with otex ear drops.

Based on this chain, in the treatment of tinnitus key position occupied by nootropic drugs and vitamins of group B. However, there is a perception that it is the B vitamins exacerbate this condition and the treatment of tinnitus can not be applied using our otex ear drops.

At present in Russia for the treatment of sensorineural hearing loss, otex express ear drops is widely used Actovegin. However, there is a combination drug instenon of the same company, which according to some sources show greater effectiveness in the treatment of sensorineural hearing loss.

Instenon Nycomed Ear drop has three components:

– geksobendin dihydrochloride (neurotrophic component);

– etofillin (vascular medicine);

– etamivan (activation of the reticular formation).

Scientists at the St. Petersburg Research Institute of the ear, nose and throat and speech Lysenko, LV, L. Golovanov conducted a study of the efficacy of instenon in the treatment the sensorineural hearing loss.

This study was conducted in patients, which included 20 people. The group consisted of patients with vascular aetiology of sensorineural hearing loss. Of 20 people approached, two with acute sensorineural hearing loss, and 18 people with chronic. The patients’ ages ranged from 26 to 74 years. The treatment consisted of parenteral and oral taking of instenon. Treatment began with intravenous drip of the drug in an amount of 2 ml per 200 ml of saline. solution (for a suggested method of intravenous drip of instenon) for 10 days. After which the patient was transferred to oral medication on a tablet or a fort-coated tablet 2-3 times daily for a month.

Otex Ear Drops

It has been obtained the following result:

Full restoration of hearing using otex ear drops: 5%.

A significant improvement in auditory function in patients with tinnitus and sensorineural hearing loss: 65%.

No result with otex ear drops: 30% (all cases of chronic sensorineural hearing loss).

In some patients noted improvement of hearing by improving speech intelligibility, which is probably due to improved metabolism and synaptic transmission in the cells of the auditory analyzer and the brain as a whole.

During treatment with otex ear drops the allergic reactions have not been identified, but two patients complained about the appearance of headache during the first intravenous injection (hereinafter referred to the complaints they have not been reported). The majority of patients with treatment reported improvement in general condition, increase efficiency, concentration, memory improvement.


Leave a Reply

Your email address will not be published. Required fields are marked *